Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Headquartered in India, Dr. Reddy's Laboratories develops and manufactures generic pharmaceutical products sold across the world. The company specializes in low-cost, easy-to-produce small-molecule generic drugs and active pharmaceutical ingredients. Its drug portfolio in recent years has included b... Headquartered in India, Dr. Reddy's Laboratories develops and manufactures generic pharmaceutical products sold across the world. The company specializes in low-cost, easy-to-produce small-molecule generic drugs and active pharmaceutical ingredients. Its drug portfolio in recent years has included biosimilar drug launches in select emerging markets and has shifted toward injectables and more complex generic products. Geographically, the company's sales are well dispersed across North America, India, and other emerging markets. Mehr anzeigen
Only immuno-oncology drug approved by various regulatory authorities around the world such as the USFDA, DCGI, EMA, MHRA, NMPA and others for the treatment of adults with recurrent or metastatic...
Dr. Reddy's Laboratories, Inc. and Senores Pharmaceuticals, Inc. today announced the launch of Ivermectin Tablets USP, 3 mg, which is bioequivalent and therapeutically equivalent to STROMECTOL®...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.77 | 5.31034482759 | 14.5 | 15.37 | 14.44 | 1613414 | 14.6771006 | CS |
| 4 | 1.03 | 7.23314606742 | 14.24 | 15.37 | 13.96 | 1561758 | 14.39998209 | CS |
| 12 | -0.70000024 | -4.3832199717 | 15.97000024 | 16.19200024 | 13.925 | 773926 | 14.51527626 | CS |
| 26 | 1.13199979 | 8.00678860649 | 14.13800021 | 16.89200025 | 13.925 | 472553 | 14.84492953 | CS |
| 52 | 1.7199998 | 12.6937252739 | 13.5500002 | 16.89200025 | 13.2640002 | 347167 | 14.69263074 | CS |
| 156 | 3.15199982 | 26.0108910149 | 12.11800018 | 16.89200025 | 9.57600014 | 264104 | 13.03537432 | CS |
| 260 | 7.17199988 | 88.5650750027 | 8.09800012 | 16.89200025 | 6.6660001 | 227321 | 12.63183641 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
